Vascular Medicine News

A selective cortisol modulator was linked to lower odds for loss of blood pressure control among adults with Cushing’s syndrome compared with placebo, according to topline results from a phase 3 trial.

Regular use of fish oil supplements was tied to an increased risk of stroke and atrial fibrillation in adults with no prior CVD, according to results of a large prospective cohort study published in BMJ Medicine.

SAN DIEGO — During 2019 and 2020, patients with pulmonary arterial hypertension lost around 8% of available workdays, according to research presented at the American Thoracic Society International Conference.

SAN DIEGO — Between 2017 and 2023, the highest rate of pulmonary embolism admissions was found in 2021 during the COVID-19 pandemic, according to research presented at the American Thoracic Society International Conference.

Preeclampsia appeared to increase primiparous women’s risk for developing arrhythmia, according to results of a real-world study published in European Journal of Preventative Cardiology.

Topical hypericin showed efficacy in treating mycosis fungoides without significant skin absorption or significant cardiac changes, according to a study.

Roche announced its lipoprotein(a) assay received breakthrough device designation from the FDA to identify patients with history of atherosclerotic CVD who may benefit from Lp(a)-lowering therapy currently in development.

Social determinants of health mediate the risk for treatment-resistant hypertension, especially among Black adults who may be disproportionately affected by barriers to equitable education and income, researchers reported.

Over the last 50 years, revascularization and pharmacotherapeutic innovations have led to significant reductions in major adverse CV events associated with both acute and chronic coronary diseases.

According to published results, perioperative IV dexamethasone was associated with decreased risk for pulmonary embolism and deep vein thrombosis after total joint arthroplasty for patients with a history of venous thromboembolism.